Jpmorgan Chase & CO Fibrogen Inc Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Fibrogen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,223 shares of FGEN stock, worth $11,312. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,223
Previous 567 115.7%
Holding current value
$11,312
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$0.31 - $0.77 $203 - $505
656 Added 115.7%
1,223 $0
Q4 2024

Feb 12, 2025
SELL
$0.3 - $0.58 $501,896 - $970,333
-1,672,988 Reduced 99.97%
567 $0
Q3 2024

Dec 26, 2024
BUY
$0.33 - $1.26 $448,204 - $1.71 Million
1,358,194 Added 430.68%
1,673,555 $669,000
Q3 2024

Nov 08, 2024
BUY
$0.33 - $1.26 $448,204 - $1.71 Million
1,358,194 Added 430.68%
1,673,555 $669,000
Q2 2024

Dec 26, 2024
SELL
$0.89 - $2.36 $1.21 Million - $3.21 Million
-1,358,194 Reduced 81.16%
315,361 $280,000
Q2 2024

Aug 12, 2024
BUY
$0.89 - $2.36 $192,920 - $511,565
216,765 Added 219.85%
315,361 $280,000
Q1 2024

Dec 26, 2024
SELL
$0.73 - $2.73 $1.15 Million - $4.3 Million
-1,574,959 Reduced 94.11%
98,596 $231,000
Q1 2024

May 10, 2024
BUY
$0.73 - $2.73 $28,079 - $105,009
38,465 Added 63.97%
98,596 $231,000
Q4 2023

Dec 26, 2024
SELL
$0.38 - $0.91 $613,101 - $1.47 Million
-1,613,424 Reduced 96.41%
60,131 $53,000
Q4 2023

Feb 12, 2024
SELL
$0.38 - $0.91 $26,468 - $63,384
-69,653 Reduced 53.67%
60,131 $53,000
Q3 2023

Nov 14, 2023
SELL
$0.79 - $2.83 $1,547 - $5,543
-1,959 Reduced 1.49%
129,784 $111,000
Q2 2023

Aug 11, 2023
SELL
$2.49 - $20.59 $91,007 - $752,543
-36,549 Reduced 21.72%
131,743 $355,000
Q1 2023

May 18, 2023
BUY
$15.95 - $25.18 $1.75 Million - $2.76 Million
109,792 Added 187.68%
168,292 $3.14 Million
Q1 2023

May 11, 2023
SELL
$15.95 - $25.18 $1.94 Million - $3.06 Million
-121,554 Reduced 67.51%
58,500 $1.09 Million
Q4 2022

Feb 13, 2023
BUY
$13.27 - $17.73 $506,688 - $676,984
38,183 Added 26.91%
180,054 $2.88 Million
Q3 2022

Nov 14, 2022
SELL
$11.4 - $14.6 $8,664 - $11,096
-760 Reduced 0.53%
141,871 $1.85 Million
Q2 2022

Aug 11, 2022
BUY
$7.94 - $12.96 $162,523 - $265,278
20,469 Added 16.76%
142,631 $1.51 Million
Q1 2022

May 11, 2022
SELL
$12.02 - $16.79 $23,174 - $32,371
-1,928 Reduced 1.55%
122,162 $1.47 Million
Q4 2021

Feb 10, 2022
SELL
$9.93 - $15.39 $11.4 Million - $17.7 Million
-1,150,876 Reduced 90.27%
124,090 $1.75 Million
Q3 2021

Nov 12, 2021
BUY
$10.18 - $26.64 $13 Million - $34 Million
1,274,966 New
1,274,966 $13 Million

Others Institutions Holding FGEN

# of Institutions
10
Shares Held
4M
Call Options Held
35K
Put Options Held
0
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $867M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email